{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T16:18:22Z","timestamp":1790093902505,"version":"4.0.1"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,8,30]]},"DOI":"10.7759\/cureus.17550","type":"journal-article","created":{"date-parts":[[2021,8,30]],"date-time":"2021-08-30T10:11:50Z","timestamp":1630318310000},"source":"Crossref","is-referenced-by-count":12,"title":["Correlation of Coronary Artery Disease and Left Ventricular Hypertrophy"],"prefix":"10.7759","author":[{"given":"Khizer","family":"Khalid","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaskamal","family":"Padda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dina","family":"Ismail","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Abdullah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dhriti","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roshini","family":"Pradeep","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Warda","family":"Hameed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayden Charlene","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gutteridge","family":"Jean-Charles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2008.06.036","article-title":"Prognostic significance of increased left ventricular mass index to mortality and sudden death in patients with stable coronary heart disease (from the Heart and Soul Study)","volume":"102","author":"Turakhia MP","year":"2008","unstructured":"Turakhia MP, Schiller NB, Whooley MA. Prognostic significance of increased left ventricular mass index to mortality and sudden death in patients with stable coronary heart disease (from the Heart and Soul Study). Am J Cardiol. 2008, 102:1131-5. 10.1016\/j.amjcard.2008.06.036","journal-title":"Am J Cardiol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.5114\/amsad.2021.105175","article-title":"Eccentric hypertrophy predicts adverse events in patients undergoing percutaneous coronary intervention for acute coronary syndrome","volume":"6","author":"Ha ET","year":"2021","unstructured":"Ha ET, Cohen M, Peterson SJ, Aronow WS. Eccentric hypertrophy predicts adverse events in patients undergoing percutaneous coronary intervention for acute coronary syndrome. Arch Med Sci Atheroscler Dis. 2021, 6:e21-7. 10.5114\/amsad.2021.105175","journal-title":"Arch Med Sci Atheroscler Dis"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1136\/jech.56.suppl_1.i8","article-title":"Left ventricular hypertrophy and risk of fatal and non-fatal stroke. EUROSTROKE: a collaborative study among research centres in Europe","volume":"56","author":"Bots ML","year":"2002","unstructured":"Bots ML, Nikitin Y, Salonen JT, et al.. Left ventricular hypertrophy and risk of fatal and non-fatal stroke. EUROSTROKE: a collaborative study among research centres in Europe. J Epidemiol Community Health. 2002, 56:i8-13. 10.1136\/jech.56.suppl_1.i8","journal-title":"J Epidemiol Community Health"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.21037\/atm.2016.06.33","article-title":"Epidemiology of coronary heart disease and acute coronary syndrome","volume":"4","author":"Sanchis-Gomar F","year":"2016","unstructured":"Sanchis-Gomar F, Perez-Quilis C, Leischik R, Lucia A. Epidemiology of coronary heart disease and acute coronary syndrome. Ann Transl Med. 2016, 4:256. 10.21037\/atm.2016.06.33","journal-title":"Ann Transl Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.111.065490","article-title":"Association between family history and coronary heart disease death across long-term follow-up in men: the Cooper Center Longitudinal Study","volume":"125","author":"Bachmann JM","year":"2012","unstructured":"Bachmann JM, Willis BL, Ayers CR, Khera A, Berry JD. Association between family history and coronary heart disease death across long-term follow-up in men: the Cooper Center Longitudinal Study. Circulation. 2012, 125:3092-8. 10.1161\/CIRCULATIONAHA.111.065490","journal-title":"Circulation"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1161\/01.hyp.25.2.155","article-title":"Hypertension and the pathogenesis of atherosclerosis. Oxidative stress and the mediation of arterial inflammatory response: a new perspective","volume":"25","author":"Alexander RW","year":"1995","unstructured":"Alexander RW. Hypertension and the pathogenesis of atherosclerosis. Oxidative stress and the mediation of arterial inflammatory response: a new perspective. Hypertension. 1995, 25:155-61. 10.1161\/01.hyp.25.2.155","journal-title":"Hypertension"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000152","article-title":"Heart disease and stroke statistics--2015 update: a report from the American Heart Association","volume":"131","author":"Mozaffarian D","year":"2015","unstructured":"Mozaffarian D, Benjamin EJ, Go AS, et al.. Heart disease and stroke statistics--2015 update: a report from the American Heart Association. Circulation. 2015, 131:e29-322. 10.1161\/CIR.0000000000000152","journal-title":"Circulation"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.115.017926","article-title":"Relation of smoking with total mortality and cardiovascular events among patients with diabetes mellitus: a meta-analysis and systematic review","volume":"132","author":"Pan A","year":"2015","unstructured":"Pan A, Wang Y, Talaei M, Hu FB. Relation of smoking with total mortality and cardiovascular events among patients with diabetes mellitus: a meta-analysis and systematic review. Circulation. 2015, 132:1795-804. 10.1161\/CIRCULATIONAHA.115.017926","journal-title":"Circulation"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000950","article-title":"Heart disease and stroke statistics-2021 update: a report from the American Heart Association","volume":"143","author":"Virani SS","year":"2021","unstructured":"Virani SS, Alonso A, Aparicio HJ, et al.. Heart disease and stroke statistics-2021 update: a report from the American Heart Association. Circulation. 2021, 143:e254-743. 10.1161\/CIR.0000000000000950","journal-title":"Circulation"},{"key":"ref10","unstructured":"Summary Health Statistics. National Health Interview Survey. (2018). Accessed: March 11, 2020: https:\/\/ftp.cdc.gov\/pub\/Health_Statistics\/NCHS\/NHIS\/SHS\/2018_SHS_Table_A-1.pdf."},{"key":"ref11","unstructured":"Centers for Disease Control and Prevention. National Health and Nutrition Examination Survey (NHANES). (2020). Accessed: April 1, 2020: https:\/\/www.cdc.gov\/nchs\/nhanes."},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.105.537878","article-title":"Pathophysiology of coronary artery disease","volume":"111","author":"Libby P","year":"2005","unstructured":"Libby P, Theroux P. Pathophysiology of coronary artery disease. Circulation. 2005, 111:3481-8. 10.1161\/CIRCULATIONAHA.105.537878","journal-title":"Circulation"},{"key":"ref13","article-title":"Harrison\u02bcs Principles of Internal Medicine","author":"Jameson JL","year":"2018","unstructured":"Jameson JL, Fauci AS, Kasper DL, Hauser SL, Longo DL, Loscalzo J. Harrison\u02bcs Principles of Internal Medicine. McGraw-Hill, New York; 2018."},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.3310\/hta11490","article-title":"Cost-effectiveness of functional cardiac testing in the diagnosis and management of coronary artery disease: a randomised controlled trial. the CECaT trial","volume":"11","author":"Sharples L","year":"2007","unstructured":"Sharples L, Hughes V, Crean A, Dyer M, Buxton M, Goldsmith K, Stone D. Cost-effectiveness of functional cardiac testing in the diagnosis and management of coronary artery disease: a randomised controlled trial. the CECaT trial. Health Technol Assess. 2007, 11:10.3310\/hta11490","journal-title":"Health Technol Assess"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCIMAGING.116.005189","article-title":"Computed tomographic perfusion improves diagnostic power of coronary computed tomographic angiography in women: analysis of the CORE320 trial (Coronary Artery Evaluation Using 320-Row Multidetector Computed Tomography Angiography and Myocardial Perfusion) according to gender","volume":"9","author":"Penagaluri A","year":"2016","unstructured":"Penagaluri A, Higgins AY, Vavere AL, et al.. Computed tomographic perfusion improves diagnostic power of coronary computed tomographic angiography in women: analysis of the CORE320 trial (Coronary Artery Evaluation Using 320-Row Multidetector Computed Tomography Angiography and Myocardial Perfusion) according to gender. Circ Cardiovasc Imaging. 2016, 9:e005189. 10.1161\/CIRCIMAGING.116.005189","journal-title":"Circ Cardiovasc Imaging"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(04)17018-9","article-title":"Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study","volume":"364","author":"Yusuf S","year":"2004","unstructured":"Yusuf S, Hawken S, Ounpuu S, et al.. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet. 2004, 364:937-952. 10.1016\/S0140-6736(04)17018-9","journal-title":"Lancet"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.109.891523","article-title":"Association of diet, exercise, and smoking modification with risk of early cardiovascular events after acute coronary syndromes","volume":"121","author":"Chow CK","year":"2010","unstructured":"Chow CK, Jolly S, Rao-Melacini P, Fox KA, Anand SS, Yusuf S. Association of diet, exercise, and smoking modification with risk of early cardiovascular events after acute coronary syndromes. Circulation. 2010, 121:750-8. 10.1161\/CIRCULATIONAHA.109.891523","journal-title":"Circulation"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1007\/BF03086277","article-title":"RESPONSE study: Randomised Evaluation of Secondary Prevention by Outpatient Nurse SpEcialists","volume":"17","author":"J\u00f8rstad HT","year":"2009","unstructured":"J\u00f8rstad HT, Alings AM, Liem AH, et al.. RESPONSE study: Randomised Evaluation of Secondary Prevention by Outpatient Nurse SpEcialists. Neth Heart J. 2009, 17:322-8. 10.1007\/BF03086277","journal-title":"Neth Heart J"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2017.05.041","article-title":"Community-based lifestyle intervention in patients with coronary artery disease: the RESPONSE-2 trial","volume":"70","author":"Minneboo M","year":"2017","unstructured":"Minneboo M, Lachman S, Snaterse M, et al.. Community-based lifestyle intervention in patients with coronary artery disease: the RESPONSE-2 trial. J Am Coll Cardiol. 2017, 70:318-27. 10.1016\/j.jacc.2017.05.041","journal-title":"J Am Coll Cardiol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa070829","article-title":"Optimal medical therapy with or without PCI for stable coronary disease","volume":"356","author":"Boden WE","year":"2007","unstructured":"Boden WE, O'Rourke RA, Teo KK, et al.. Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med. 2007, 356:1503-16. 10.1056\/NEJMoa070829","journal-title":"N Engl J Med"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2013.05.033","article-title":"Outcomes after complete versus incomplete revascularization of patients with multivessel coronary artery disease: a meta-analysis of 89,883 patients enrolled in randomized clinical trials and observational studies","volume":"62","author":"Garcia S","year":"2013","unstructured":"Garcia S, Sandoval Y, Roukoz H, Adabag S, Canoniero M, Yannopoulos D, Brilakis ES. Outcomes after complete versus incomplete revascularization of patients with multivessel coronary artery disease: a meta-analysis of 89,883 patients enrolled in randomized clinical trials and observational studies. J Am Coll Cardiol. 2013, 62:1421-31. 10.1016\/j.jacc.2013.05.033","journal-title":"J Am Coll Cardiol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-199117002-00002","article-title":"Clinical significance of left ventricular hypertrophy: insights from the Framingham Study","volume":"17","author":"Levy D","year":"1991","unstructured":"Levy D. Clinical significance of left ventricular hypertrophy: insights from the Framingham Study. J Cardiovasc Pharmacol. 1991, 17:S1-6. 10.1097\/00005344-199117002-00002","journal-title":"J Cardiovasc Pharmacol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1038\/jhh.2011.104","article-title":"Prevalence of left-ventricular hypertrophy in hypertension: an updated review of echocardiographic studies","volume":"26","author":"Cuspidi C","year":"2012","unstructured":"Cuspidi C, Sala C, Negri F, Mancia G, Morganti A. Prevalence of left-ventricular hypertrophy in hypertension: an updated review of echocardiographic studies. J Hum Hypertens. 2012, 26:343-9. 10.1038\/jhh.2011.104","journal-title":"J Hum Hypertens"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/5720758","article-title":"Pathological left ventricular hypertrophy and stem cells: current evidence and new perspectives","volume":"2016","author":"Marketou ME","year":"2016","unstructured":"Marketou ME, Parthenakis F, Vardas PE. Pathological left ventricular hypertrophy and stem cells: current evidence and new perspectives. Stem Cells Int. 2016, 2016:5720758. 10.1155\/2016\/5720758","journal-title":"Stem Cells Int"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2261-14-136","article-title":"Prevalence and risk factors of abnormal left ventricular geometrical patterns in untreated hypertensive patients","volume":"14","author":"Li H","year":"2014","unstructured":"Li H, Pei F, Shao L, et al.. Prevalence and risk factors of abnormal left ventricular geometrical patterns in untreated hypertensive patients. BMC Cardiovasc Disord. 2014, 14:136. 10.1186\/1471-2261-14-136","journal-title":"BMC Cardiovasc Disord"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1038\/ajh.2008.252","article-title":"Obesity promotes left ventricular concentric rather than eccentric geometric remodeling and hypertrophy independent of blood pressure","volume":"21","author":"Woodiwiss AJ","year":"2008","unstructured":"Woodiwiss AJ, Libhaber CD, Majane OH, Libhaber E, Maseko M, Norton GR. Obesity promotes left ventricular concentric rather than eccentric geometric remodeling and hypertrophy independent of blood pressure. Am J Hypertens. 2008, 21:1144-51. 10.1038\/ajh.2008.252","journal-title":"Am J Hypertens"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2008.02.082","article-title":"Association between diabetes mellitus and left ventricular hypertrophy in a multiethnic population","volume":"101","author":"Eguchi K","year":"2008","unstructured":"Eguchi K, Boden-Albala B, Jin Z, Rundek T, Sacco RL, Homma S, Di Tullio MR. Association between diabetes mellitus and left ventricular hypertrophy in a multiethnic population. Am J Cardiol. 2008, 101:1787-91. 10.1016\/j.amjcard.2008.02.082","journal-title":"Am J Cardiol"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1097\/01.hjh.0000570852.49947.8d","article-title":"Association between hypertension onset age and ECG-LVH in a population sample of 2867 individuals","volume":"37","author":"Niiranen T","year":"2019","unstructured":"Niiranen T, Suvila K, Lehtonen A. Association between hypertension onset age and ECG-LVH in a population sample of 2867 individuals. J Hypertens. 2019, 37:48. 10.1097\/01.hjh.0000570852.49947.8d","journal-title":"J Hypertens"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.119.13069","article-title":"Early onset hypertension is associated with hypertensive end-organ damage already by midlife","volume":"74","author":"Suvila K","year":"2019","unstructured":"Suvila K, McCabe EL, Lehtonen A, Ebinger JE, Lima JA, Cheng S, Niiranen TJ. Early onset hypertension is associated with hypertensive end-organ damage already by midlife. Hypertension. 2019, 74:305-312. 10.1161\/HYPERTENSIONAHA.119.13069","journal-title":"Hypertension"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1186\/s12872-017-0637-8","article-title":"Models for improved diagnosis of left ventricular hypertrophy based on conventional electrocardiographic criteria","volume":"17","author":"Lu N","year":"2017","unstructured":"Lu N, Zhu JX, Yang PX, Tan XR. Models for improved diagnosis of left ventricular hypertrophy based on conventional electrocardiographic criteria. BMC Cardiovasc Disord. 2017, 17:217. 10.1186\/s12872-017-0637-8","journal-title":"BMC Cardiovasc Disord"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCEP.115.003629","article-title":"Clinical diagnosis of electrical versus anatomic left ventricular hypertrophy: prognostic and therapeutic implications","volume":"9","author":"Aro AL","year":"2016","unstructured":"Aro AL, Chugh SS. Clinical diagnosis of electrical versus anatomic left ventricular hypertrophy: prognostic and therapeutic implications. Circ Arrhythm Electrophysiol. 2016, 9:e003629. 10.1161\/CIRCEP.115.003629","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.55.4.613","article-title":"Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method","volume":"55","author":"Devereux RB","year":"1977","unstructured":"Devereux RB, Reichek N. Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method. Circulation. 1977, 55:613-8. 10.1161\/01.cir.55.4.613","journal-title":"Circulation"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcmg.2008.05.012","article-title":"Prognostic implications of left ventricular mass and geometry following myocardial infarction: the VALIANT (VALsartan In Acute myocardial iNfarcTion) Echocardiographic Study","volume":"1","author":"Verma A","year":"2008","unstructured":"Verma A, Meris A, Skali H, et al.. Prognostic implications of left ventricular mass and geometry following myocardial infarction: the VALIANT (VALsartan In Acute myocardial iNfarcTion) Echocardiographic Study. JACC Cardiovasc Imaging. 2008, 1:582-91. 10.1016\/j.jcmg.2008.05.012","journal-title":"JACC Cardiovasc Imaging"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.1632","article-title":"Concentric vs. eccentric remodelling in heart failure with reduced ejection fraction: clinical characteristics, pathophysiology and response to treatment","volume":"22","author":"Nauta JF","year":"2020","unstructured":"Nauta JF, Hummel YM, Tromp J, et al.. Concentric vs. eccentric remodelling in heart failure with reduced ejection fraction: clinical characteristics, pathophysiology and response to treatment. Eur J Heart Fail. 2020, 22:1147-55. 10.1002\/ejhf.1632","journal-title":"Eur J Heart Fail"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcmg.2017.04.012","article-title":"LV mass independently predicts mortality and need for future revascularization in\u00a0patients undergoing diagnostic coronary angiography","volume":"11","author":"Abdi-Ali A","year":"2018","unstructured":"Abdi-Ali A, Miller RJ, Southern D, et al.. LV mass independently predicts mortality and need for future revascularization in\u00a0patients undergoing diagnostic coronary angiography. JACC Cardiovasc Imaging. 2018, 11:423-33. 10.1016\/j.jcmg.2017.04.012","journal-title":"JACC Cardiovasc Imaging"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1016\/s0735-1097(00)00511-8","article-title":"Echocardiographic predictors of clinical outcome in patients with left ventricular dysfunction enrolled in the SOLVD registry and trials: significance of left ventricular hypertrophy. Studies of left ventricular dysfunction","volume":"35","author":"Qui\u00f1ones MA","year":"2000","unstructured":"Qui\u00f1ones MA, Greenberg BH, Kopelen HA, et al.. Echocardiographic predictors of clinical outcome in patients with left ventricular dysfunction enrolled in the SOLVD registry and trials: significance of left ventricular hypertrophy. Studies of left ventricular dysfunction. J Am Coll Cardiol. 2000, 35:1237-1244. 10.1016\/s0735-1097(00)00511-8","journal-title":"J Am Coll Cardiol"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.103.19.2346","article-title":"Echocardiographic and electrocardiographic diagnoses of left ventricular hypertrophy predict mortality independently of each other in a population of elderly men","volume":"103","author":"Sundstr\u00f6m J","year":"2001","unstructured":"Sundstr\u00f6m J, Lind L, Arnl\u00f6v J, Zethelius B, Andr\u00e9n B, Lithell HO. Echocardiographic and electrocardiographic diagnoses of left ventricular hypertrophy predict mortality independently of each other in a population of elderly men. Circulation. 2001, 103:2346-51. 10.1161\/01.cir.103.19.2346","journal-title":"Circulation"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1161\/01.hyp.35.2.580","article-title":"Continuous relation between left ventricular mass and cardiovascular risk in essential hypertension","volume":"35","author":"Schillaci G","year":"2000","unstructured":"Schillaci G, Verdecchia P, Porcellati C, Cuccurullo O, Cosco C, Perticone F. Continuous relation between left ventricular mass and cardiovascular risk in essential hypertension. Hypertension. 2000, 35:580-6. 10.1161\/01.hyp.35.2.580","journal-title":"Hypertension"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1097\/00000441-199903000-00006","article-title":"Why is left ventricular hypertrophy so predictive of morbidity and mortality?","volume":"317","author":"Benjamin EJ","year":"1999","unstructured":"Benjamin EJ, Levy D. Why is left ventricular hypertrophy so predictive of morbidity and mortality?. Am J Med Sci. 1999, 317:168-175. 10.1097\/00000441-199903000-00006","journal-title":"Am J Med Sci"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.311.7000.273","article-title":"Left ventricular hypertrophy","volume":"311","author":"Chambers J","year":"1995","unstructured":"Chambers J. Left ventricular hypertrophy. BMJ. 1995, 311:273-4. 10.1136\/bmj.311.7000.273","journal-title":"BMJ"},{"key":"ref41","article-title":"Alterations in the coronary circulation in hypertrophied ventricles","volume":"75","author":"Marcus ML","year":"1987","unstructured":"Marcus ML, Harrison DG, Chilian WM, et al.. Alterations in the coronary circulation in hypertrophied ventricles. Circulation. 1987, 75:I19-25.","journal-title":"Circulation"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2004.03.067","article-title":"Platelet indexes in relation to target organ damage in high-risk hypertensive patients: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT)","volume":"44","author":"Nadar SK","year":"2004","unstructured":"Nadar SK, Blann AD, Kamath S, Beevers DG, Lip GY. Platelet indexes in relation to target organ damage in high-risk hypertensive patients: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT). J Am Coll Cardiol. 2004, 44:415-22. 10.1016\/j.jacc.2004.03.067","journal-title":"J Am Coll Cardiol"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(84)90255-8","article-title":"Whole blood viscosity as a determinant of cardiac hypertrophy in systemic hypertension","volume":"54","author":"Devereux RB","year":"1984","unstructured":"Devereux RB, Drayer JI, Chien S, et al.. Whole blood viscosity as a determinant of cardiac hypertrophy in systemic hypertension. Am J Cardiol. 1984, 54:592-595. 10.1016\/0002-9149(84)90255-8","journal-title":"Am J Cardiol"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1016\/s0002-9149(97)00749-2","article-title":"Relation of endothelium, thrombogenesis, and hemorheology in systemic hypertension to ethnicity and left ventricular hypertrophy","volume":"80","author":"Lip GY","year":"1997","unstructured":"Lip GY, Blann AD, Jones AF, Lip PL, Beevers DG. Relation of endothelium, thrombogenesis, and hemorheology in systemic hypertension to ethnicity and left ventricular hypertrophy. Am J Cardiol. 1997, 80:1566-1571. 10.1016\/s0002-9149(97)00749-2","journal-title":"Am J Cardiol"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1016\/0735-1097(94)00316-i","article-title":"Association of carotid atherosclerosis and left ventricular hypertrophy","volume":"25","author":"Roman MJ","year":"1995","unstructured":"Roman MJ, Pickering TG, Schwartz JE, Pini R, Devereux RB. Association of carotid atherosclerosis and left ventricular hypertrophy. J Am Coll Cardiol. 1995, 25:83-90. 10.1016\/0735-1097(94)00316-i","journal-title":"J Am Coll Cardiol"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.0000118584.33350.7d","article-title":"Hypertensive myocardial fibrosis and diastolic dysfunction: another model of inflammation?","volume":"43","author":"Kuwahara F","year":"2004","unstructured":"Kuwahara F, Kai H, Tokuda K, Takeya M, Takeshita A, Egashira K, Imaizumi T. Hypertensive myocardial fibrosis and diastolic dysfunction: another model of inflammation?. Hypertension. 2004, 43:739-45. 10.1161\/01.HYP.0000118584.33350.7d","journal-title":"Hypertension"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2005.03.054","article-title":"Relation of left ventricular concentric remodeling to levels of C-reactive protein and serum amyloid A in patients with essential hypertension","volume":"96","author":"Tsioufis C","year":"2005","unstructured":"Tsioufis C, Stougiannos P, Kakkavas A, et al.. Relation of left ventricular concentric remodeling to levels of C-reactive protein and serum amyloid A in patients with essential hypertension. Am J Cardiol. 2005, 96:252-6. 10.1016\/j.amjcard.2005.03.054","journal-title":"Am J Cardiol"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1053\/ajkd.2002.36891","article-title":"Increased C-reactive protein following hemodialysis predicts cardiac hypertrophy in chronic hemodialysis patients","volume":"40","author":"Park CW","year":"2002","unstructured":"Park CW, Shin YS, Kim CM, et al.. Increased C-reactive protein following hemodialysis predicts cardiac hypertrophy in chronic hemodialysis patients. Am J Kidney Dis. 2002, 40:1230-9. 10.1053\/ajkd.2002.36891","journal-title":"Am J Kidney Dis"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-108-1-7","article-title":"Echocardiographically detected left ventricular hypertrophy: prevalence and risk factors. The Framingham Heart Study","volume":"108","author":"Levy D","year":"1988","unstructured":"Levy D, Anderson KM, Savage DD, Kannel WB, Christiansen JC, Castelli WP. Echocardiographically detected left ventricular hypertrophy: prevalence and risk factors. The Framingham Heart Study. Ann Intern Med. 1988, 108:7-13. 10.7326\/0003-4819-108-1-7","journal-title":"Ann Intern Med"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1016\/s0002-9149(01)01807-0","article-title":"Impact of coronary artery disease on left ventricular systolic function and geometry in hypertensive patients with left ventricular hypertrophy (the LIFE study)","volume":"88","author":"Zabalgoitia M","year":"2001","unstructured":"Zabalgoitia M, Berning J, Koren MJ, et al.. Impact of coronary artery disease on left ventricular systolic function and geometry in hypertensive patients with left ventricular hypertrophy (the LIFE study). Am J Cardiol. 2001, 88:646-650. 10.1016\/s0002-9149(01)01807-0","journal-title":"Am J Cardiol"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjhyper.2007.04.021","article-title":"The cardiovascular risk factor, left ventricular hypertrophy, is highly prevalent in stable, treated angina pectoris","volume":"20","author":"Ang DS","year":"2007","unstructured":"Ang DS, Pringle SD, Struthers AD. The cardiovascular risk factor, left ventricular hypertrophy, is highly prevalent in stable, treated angina pectoris. Am J Hypertens. 2007, 20:1029-35. 10.1016\/j.amjhyper.2007.04.021","journal-title":"Am J Hypertens"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2019.03.059","article-title":"Left ventricular hypertrophy contributes to Myocardial Ischemia in Non-obstructive Coronary Artery Disease (the MicroCAD study)","volume":"286","author":"Eskerud I","year":"2019","unstructured":"Eskerud I, Gerdts E, Larsen TH, L\u00f8nnebakken MT. Left ventricular hypertrophy contributes to Myocardial Ischemia in Non-obstructive Coronary Artery Disease (the MicroCAD study). Int J Cardiol. 2019, 286:1-6. 10.1016\/j.ijcard.2019.03.059","journal-title":"Int J Cardiol"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1016\/s0735-1097(98)00131-4","article-title":"Influence of left ventricular geometric patterns on prognosis in patients with or without coronary artery disease","volume":"31","author":"Ghali JK","year":"1998","unstructured":"Ghali JK, Liao Y, Cooper RS. Influence of left ventricular geometric patterns on prognosis in patients with or without coronary artery disease. J Am Coll Cardiol. 1998, 31:1635-1640. 10.1016\/s0735-1097(98)00131-4","journal-title":"J Am Coll Cardiol"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.107.087890","article-title":"Left ventricular hypertrophy, subclinical atherosclerosis, and inflammation","volume":"49","author":"Mehta SK","year":"2007","unstructured":"Mehta SK, Rame JE, Khera A, et al.. Left ventricular hypertrophy, subclinical atherosclerosis, and inflammation. Hypertension. 2007, 49:1385-91. 10.1161\/HYPERTENSIONAHA.107.087890","journal-title":"Hypertension"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000012067","article-title":"Impact of left ventricular hypertrophy on long-term clinical outcomes in hypertensive patients who underwent successful percutaneous coronary intervention with drug-eluting stents","volume":"97","author":"Kim YH","year":"2018","unstructured":"Kim YH, Her AY, Choi BG, et al.. Impact of left ventricular hypertrophy on long-term clinical outcomes in hypertensive patients who underwent successful percutaneous coronary intervention with drug-eluting stents. Medicine (Baltimore). 2018, 97:e12067. 10.1097\/MD.0000000000012067","journal-title":"Medicine (Baltimore)"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.3109\/10641963.2015.1047943","article-title":"Left ventricular hypertrophy on long-term cardiovascular outcomes in patients with ST-elevation myocardial infarction","volume":"37","author":"Park JS","year":"2015","unstructured":"Park JS, Shin JS, Lee YH, et al.. Left ventricular hypertrophy on long-term cardiovascular outcomes in patients with ST-elevation myocardial infarction. Clin Exp Hypertens. 2015, 37:674-9. 10.3109\/10641963.2015.1047943","journal-title":"Clin Exp Hypertens"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-105-2-173","article-title":"Value of echocardiographic measurement of left ventricular mass in predicting cardiovascular morbid events in hypertensive men","volume":"105","author":"Casale PN","year":"1986","unstructured":"Casale PN, Devereux RB, Milner M, Zullo G, Harshfield GA, Pickering TG, Laragh JH. Value of echocardiographic measurement of left ventricular mass in predicting cardiovascular morbid events in hypertensive men. Ann Intern Med. 1986, 105:173-8. 10.7326\/0003-4819-105-2-173","journal-title":"Ann Intern Med"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.91.3.698","article-title":"Comparison of five antihypertensive monotherapies and placebo for change in left ventricular mass in patients receiving nutritional-hygienic therapy in the Treatment of Mild Hypertension Study (TOMHS)","volume":"91","author":"Liebson PR","year":"1995","unstructured":"Liebson PR, Grandits GA, Dianzumba S, Prineas RJ, Grimm RH Jr, Neaton JD, Stamler J. Comparison of five antihypertensive monotherapies and placebo for change in left ventricular mass in patients receiving nutritional-hygienic therapy in the Treatment of Mild Hypertension Study (TOMHS). Circulation. 1995, 91:698-706. 10.1161\/01.cir.91.3.698","journal-title":"Circulation"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.1016\/j.pcad.2006.02.001","article-title":"From left ventricular hypertrophy to congestive heart failure: management of hypertensive heart disease","volume":"48","author":"Gradman AH","year":"2006","unstructured":"Gradman AH, Alfayoumi F. From left ventricular hypertrophy to congestive heart failure: management of hypertensive heart disease. Prog Cardiovasc Dis. 2006, 48:326-41. 10.1016\/j.pcad.2006.02.001","journal-title":"Prog Cardiovasc Dis"},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjhyper.2007.06.002","article-title":"Left-ventricular hypertrophy and coronary artery disease","volume":"20","author":"Pierdomenico SD","year":"2007","unstructured":"Pierdomenico SD. Left-ventricular hypertrophy and coronary artery disease. Am J Hypertens. 2007, 20:1036-7. 10.1016\/j.amjhyper.2007.06.002","journal-title":"Am J Hypertens"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.1093\/ajh\/5.2.95","article-title":"Reversal of left ventricular hypertrophy in hypertensive patients: a metaanalysis of 109 treatment studies","volume":"5","author":"Dahl\u00f6f B","year":"1992","unstructured":"Dahl\u00f6f B, Pennert K, Hansson L. Reversal of left ventricular hypertrophy in hypertensive patients: a metaanalysis of 109 treatment studies. Am J Hypertens. 1992, 5:95-110. 10.1093\/ajh\/5.2.95","journal-title":"Am J Hypertens"},{"key":"ref62","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1983.99","article-title":"Cardiac muscle mass during vasodilation therapy of hypertension","volume":"33","author":"Drayer JI","year":"1983","unstructured":"Drayer JI, Gardin JM, Weber MA, Aronow WS. Cardiac muscle mass during vasodilation therapy of hypertension. Clin Pharmacol Ther. 1983, 33:727-32. 10.1038\/clpt.1983.99","journal-title":"Clin Pharmacol Ther"},{"key":"ref63","doi-asserted-by":"publisher","DOI":"10.1016\/0735-1097(90)90470-a","article-title":"Effects of captopril and minoxidil on left ventricular hypertrophy in resistant hypertensive patients: a 6 month double-blind comparison","volume":"16","author":"Julien J","year":"1990","unstructured":"Julien J, Dufloux MA, Prasquier R, et al.. Effects of captopril and minoxidil on left ventricular hypertrophy in resistant hypertensive patients: a 6 month double-blind comparison. J Am Coll Cardiol. 1990, 16:137-142. 10.1016\/0735-1097(90)90470-a","journal-title":"J Am Coll Cardiol"},{"key":"ref64","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000091405.00772.6E","article-title":"Effects of eplerenone, enalapril, and eplerenone\/enalapril in patients with essential hypertension and left ventricular hypertrophy: the 4E-left ventricular hypertrophy study","volume":"108","author":"Pitt B","year":"2003","unstructured":"Pitt B, Reichek N, Willenbrock R, et al.. Effects of eplerenone, enalapril, and eplerenone\/enalapril in patients with essential hypertension and left ventricular hypertrophy: the 4E-left ventricular hypertrophy study. Circulation. 2003, 108:1831-8. 10.1161\/01.CIR.0000091405.00772.6E","journal-title":"Circulation"},{"key":"ref65","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.53.9.2501","article-title":"Regeneration of the heart in diabetes by selective copper chelation","volume":"53","author":"Cooper GJ","year":"2004","unstructured":"Cooper GJ, Phillips AR, Choong SY, et al.. Regeneration of the heart in diabetes by selective copper chelation. Diabetes. 2004, 53:2501-8. 10.2337\/diabetes.53.9.2501","journal-title":"Diabetes"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/68490-correlation-of-coronary-artery-disease-and-left-ventricular-hypertrophy","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:34:43Z","timestamp":1707507283000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/68490-correlation-of-coronary-artery-disease-and-left-ventricular-hypertrophy"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,30]]},"references-count":65,"URL":"https:\/\/doi.org\/10.7759\/cureus.17550","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8,30]]}}}